UK Biobank has my data, but I’m not worried. I know the benefits are too great to consider pulling out | Polly Toynbee
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- UK Biobank posted a data listing on Alibaba, but the listing contained no personal identifiers and was swiftly removed by Chinese authorities.
- Patrick Vallance warned that further attempts to sell UK Biobank data in China are likely, highlighting ongoing security concerns.
- Sir Rory Collins personally offered to speak with any anxious participant, and only about 100 inquiries led to 50 withdrawals from the cohort.
- Alibaba briefly hosted the Biobank listing before Chinese regulators ordered its removal, preventing any sale.
- NHS is credited for providing the centralized health data that underpins the Biobank's research breakthroughs, such as early detection of motor neurone disease and a gene linked to most Alzheimer's cases.
Why it matters: UK Biobank retains 500,000 participants, only 50 withdrew, preserving a massive research resource that fuels UK health innovation; Chinese rogue actors lose a potential illicit profit, reinforcing trust in UK data governance.
Ask SkimNews
